Hong Kong College of Cardiology

Hong Kong Society of
Congenital and Structural
Heart Disease

Hong Kong Society of
Biological Psychiatry

The Hong Kong Pain Society

Register Now!
CME Accreditation:
HKMA, HKCA, HKCEM, HKCFP, HKCOG, HKCPaed, HKCP, HKCPsy, HKCR, CDSHK, CSHK: Conference: 5 points, Lunch: 1 point
HKCPath: Conference: 5.5 points, Lunch: 1 point
Conference Update:

Introduction to Personalized Medicine

Today, we wait for a disease to occur then act. The future is predictive, preventive & personalized.
Personalized medicine is on the front lines now. We are moving towards a data-driven, evidence based, individualized approach where the patient’s genetic makeup is used to guide treatment.
The conference will be exploring the ways in which personalized & precision medicine is reshaping healthcare.
  • Genetics can account for 20-95% of variability in an individual’s response to drugs
  • 2.2 million severe Adverse Drug Events (ADEs) occur every year
  • ADEs are the THIRD leading cause of death with over 100,000 deaths annually
The Schedule

Time: 10:00 am - 4:30 pm
Venue: The Langham Hotel, 8 Peking Road, Tsim Sha Tsui
(For non-members of The Society of Physicians of Hong Kong,
please pay $100 on admission on the event day) 

Lunch Seminar
Time: 1:00 pm - 3:00 pm
Venue: HKMA Dr. Li Shu Pui Professional Education Centre
2/F, Chinese Club Building, 21-22 Connaught Road Central, Hong Kong
(Free for all medical professionals) 

FREE for Members and Associated Members of The Society of Physicians of Hong Kong
CME Accreditation
HKMA: Conference: 5 points, Lunch: 1 point
HKCA: Conference: 5 points, Lunch: 1 point
HKCEM: Conference: 5 points, Lunch: 1 point
HKCFP: Conference: 5 points, Lunch: 1 point
HKCOG: Conference: 5 points, Lunch: 1 point
HKCPaed: Conference: 5 points, Lunch: 1 point
HKCPath: Conference: 5.5 points, Lunch: 1 point
HKCP: Conference: 5 points, Lunch: 1 point
HKCPsy: Conference: 5 points, Lunch: 1 point
HKCR: Conference: 5 points, Lunch: 1 point
CDSHK: Conference: 5 points, Lunch: 1 point
CSHK: Conference: 5 points, Lunch: 1 point
Limited seats available! Do RSVP early to Prenetics sales representative or web registration at the form below.

Renowned Speakers
Prof. Brian Tomlinson 
BSc, MBBS, MD, MRCP(UK), FHKCP, FRCP(Lond, Edin, Glasg), FHKAM(Medicine), FCP, FACP 
Former Head, Dept. of Clinical Pharmacology, 
Specialist in Internal Medicine and Clinical Pharmacology,
Adjunct Professor, 
Department of Medicine and Therapeutics,
The Chinese University of Hong Kong
Prof. Stephen Tsui
Professor, School of Biomedical Sciences,
Head, Division of Genomics and Bioinformatics,
Associate Director, CUHK-BGI Innovation Institute of Trans-omics,
Director, Centre for Microbial Genomics and Proteomics,
Director, Hong Kong Bioinformatics Centre,
The Chinese University of Hong Kong.
Dr Tsui Kwok-Wing Stephen is currently a Professor in the School of Biomedical Sciences, the Head of Division of Genomics and Bioinformatics and the Director of Hong Kong Bioinformatics Centre of the Chinese University of Hong Kong (CUHK).  In 1995, he received his PhD degree in Biochemistry at CUHK. He was then appointed as an Assistant Professor in the Biochemistry Department in 1997 and promoted to the professorship in 2004.  He was also a former member of the International HapMap Consortium and worked on the single nucleotide polymorphisms of human chromosome 3p.  During the SARS outbreak in 2003, his team was one of the earliest teams that cracked the complete genome of the SARS-coronavirus.  Totally, he has published more than 173 scientific papers in international journals, including Nature, NEJM, Lancet, PNAS, Circulation, JACI and Genome Biology and two US patents. His major research interests are next generation sequencing, bioinformatics, human genetic diseases and molecular microbiology.
Professor Brian Tomlinson is Chair Professor in the Department of Medicine and Therapeutics and Head of the Division of Clinical Pharmacology at the Chinese University of Hong Kong and honorary Consultant Physician at the Prince of Wales Hospital, Hong Kong. He trained in internal medicine and Clinical Pharmacology at the Middlesex Hospital Medical School and University College Hospital, London. He received his MD from the University of London and was awarded Fellowships from the Royal College of Physicians of London, the Royal College of Physicians of Edinburgh, the Royal College of Physicians and Surgeons of Glasgow and the Hong Kong Academy of Medicine. He also holds Fellowships of the American College of Physicians, the American College of Clinical Pharmacology, the Hong Kong College of Physicians and the Hong Kong College of Cardiology. His clinical and research interests include the clinical pharmacology, toxicology and pharmacogenetics of drugs, particularly in the cardiovascular field, and the pathogenesis and treatment of hyperlipidaemia, hypertension, the metabolic syndrome and diabetes. He has trained over 30 postgraduate students and is an author of over 350 publications and over 500 conference abstracts and has given numerous invited lectures. He is a reviewer for many journals and serves on several Editorial Boards and is President of the Asian-Pacific Society of Atherosclerosis and Vascular Diseases and Secretary General of the Pacific Rim Association for Clinical Pharmacogenetics.
Prof. Michael Yang
Dr. Senthil Sundaram 

Head & Chair Professor,
Deptment of Biomedical Science, City University of Hong Kong

Professor of Pediatrics and Neurology,
Wayne State University,
PET center, Children’s Hospital of Michigan
Professor Yang is a co-founder of Prenetics (formerly named Multigene) as a spin-off from City University focusing on the development of molecular diagnostics for early detection of diseases. Professor Yang’s research interest focuses on the study of molecular processes in stem cells and cancer stem cells interacting with micro-environments, and the development of biochip technology and nano-medicine for research and clinical applications. Professor Yang has published over 200 peer-reviewed scientific papers and 40 patents/patent applications. He has delivered more than 80 invited lectures in international conferences, and trained 24 Ph.D./M.Phil. students and numerous postdoctoral fellows in his laboratory. He holds honorary professorships in University of Central Lancashire, Zhejiang University, and the Third Military Medical University. Professor Yang serves in the Grant Review Boards of Hong Kong Government Health and Medical Research Fund and Innovation and Technology Fund. He has been awarded the Chunhui Scholar Award by the Ministry of Education in China in 2003, the K. C. Wong Foundation Award in 2004, the Shenzhen Science and Technology Innovation Award in 2006, and the Hong Kong Technological Achievement Grand Award in 2007. Professor Yang obtained his Ph.D. from University of Toronto and postdoctoral training in the Scripps Research Institute in USA.
Dr. Sundaram, MD serves as Chief Clinical Officer and is highly recognised for his experience as both a physician-scientist leading genetic research programs in the USA. Dr. Sundaram has discovered genetic mutations and rare genetic variants causing different neurological diseases using cutting edge next-gen sequencing technologies such as whole exome sequencing. Dr. Sundaram’s research articles have been published in reputed, high-impact journals such as Neurology, Annals of Neurology, cerebral Cortex etc. Dr. Sundaram’s research works have been funded by the National Institute of Health (NIH), USA. Dr. Sundaram also serves as a reviewer of journals and NIH study sections.
Dr. Jason P. Caplan 
Dr. Carol Isaacson Barash 
Founder & Managing Partner,
Helix Health Advisors
Editor-in-Chief, Journal of Applied & Translational Genomics
Professor & Chair of Psychiatry
Creighton University School of Medicine,
St. Joseph's Hospital and Medical Center
Jason P. Caplan, MD, FAPM is the Chair of Psychiatry at St. Joseph’s Hospital and Medical Center. Dr. Caplan is board certified by the American Board of Psychiatry and Neurology in Psychiatry and Psychosomatic Medicine.
Dr. Caplan’s expertise centers on the psychiatric care of the medically ill patient, particularly on the prevention and management of delirium. He has authored many journal articles and textbook chapters on various aspects of the practice of psychiatry in the medical hospital and serves on the editorial board of two major psychiatric journals.
He has been named a Fellow of the Academy of Psychosomatic Medicine and is a member of the American Psychiatric Association, Association for Academic Psychiatry, and the American Neuropsychiatric Association. Dr. Caplan received his medical degree from the Creighton University School of Medicine. He completed his residency in psychiatry at the Harvard Longwood Psychiatry Residency Training Program and fellowship in psychosomatic medicine/consultation psychiatry at the Massachusetts General Hospital.
Carol Isaacson Barash is Founder and Managing Partner at Helix Health Advisors which helps clients in life sciences, genetic diagnostics, and convergent technologies to commercialize, solve adoption challenges, improve physician-patient-consumer engagement, and manage bioethics concerns. Dr. Barash is a recognized expert in personalized medicine with 20 years of experience serving industry, research institutions, non-profits, academic medical centers and communications firms in the US and abroad. She has served as senior management for several molecular diagnostic and health IT start-ups, as expert on barriers to integrating new genetic knowledge into clinical decision-making, and molecular diagnostic content developer focusing on
oncology, pharmacogenetics and pharmacogenomics, most recently for McKesson
Health Solutions.
Dr. Barash is the Editor-in-Chief of the Journal of Applied & Translational Genomics, Elsevier, lectures on personalized medicine at Regis College, Graduate Program of Regulatory Affairs & Clinical Research Management, College of Sciences, Nursing and Health Professions and serves as bioethics resource expert for Bioethics Beyond Borders, Division of Science, Technology & Ethics, UNESCO. Recently, she served as Chair of the Ethics Committee and co-Chair of the Education Committee of the International Human Variome Project
She authored ‘’Just Genes: The Ethics of Genetic Technologies”, Praeger, 2007, has contributed chapters to several books and has published over 40 journal articles. Prior to starting Helix Health Advisors, Carol founded and managed Genetics, Ethics & Policy Consulting. Carol earned her Ph.D. from the University of Chicago/Boston College and her B.A. from Bates College/Manchester College, The University of Oxford, U.K.
Dr. John Francis Peppin
Dr. Deepak Voora
Assistant Professor of Medicine, Department of Medicine,
Duke University School of Medicine
Clinical Adjunct Professor,
College of Osteopathic Medicine,
Marian University  
Dr. Peppin is board certified in Internal Medicine and pain medicine and is a certified EPEC trainer.  Elected Fellow of the American College of Physicians, a Kentucky Colonel in 2009 and PainWeek 2011 Clinician of the Year.  He was formerly Medical Director, Global Pharmaceuticals, Mallinckrodt Pharmaceuticals in St. Louis; and Chief Medical Officer for Castle Medical in Atlanta Georgia.  He has published over 65 articles in the fields of pain management, palliative care and bioethics and edited books and given numerous lectures, papers and posters at conferences nationally and internationally.  Former reviewer for multiple journals and the Cochrane PaPaS Group.
Deepak Voora is a highly motivated physician-scientist with a long-standing interest in cardiovascular pharmacogenomics research. Since 2005, initially under the mentorship of Brian Gage, MD, then subsequently as a post-doctoral fellow under mentorship of Geoffrey Ginsburg, MD, PhD, and then as a junior faculty member, he has been focused on the area of cardiovascular pharmacogenomics that spans from discovery to translation into the clinic. Over the time his research has expanded from identifying single genetic variants to describe drug response to a broad “systems pharmacology” approach that studies the in vivo response to cardiovascular drugs in human subjects.
Limited Seats Available! 
Register Now
No Confirmation is sent for registration. Unsuccessful applicants will be informed.
Contact Us
Phone: 2210-9588
Fax: 22101-9580
Unit 03, 10/F, Manning House,
38-48 Queen's Road Central,
Hong Kong